Journal
CHEMICAL SCIENCE
Volume 13, Issue 18, Pages 5155-5163Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/d2sc00459c
Keywords
-
Categories
Funding
- National Natural Science Foundation of China [21874103, 22074112]
Ask authors/readers for more resources
DNAzyme-mediated gene regulation and photodynamic cancer therapy achieved using dynamic DNA nanomaterials with self-enhanced efficacy, providing a potential therapeutic approach for gene modulation.
Nucleic acid therapeutics has reached clinical utility through modulating gene expression. As a potential oligonucleotide drug, DNAzyme has RNA-cleaving activity for gene silencing, but faces challenges due to the lack of a safe and effective delivery vehicle and low in vivo catalytic activity. Here we describe DNAzyme-mediated gene regulation using dynamic DNA nanomaterials with intrinsic biocompatibility, stability, tumor-targeted delivery and uptake, and self-enhanced efficacy. We assemble programmable DNA nanosponges to package and deliver diverse nucleic acid drugs and therapeutic agents such as aptamer, DNAzyme and its cofactor precursor, and photosensitizer in one pot through the rolling circle amplification reaction, formulating a controllable nanomedicine using encoded instructions. Upon environmental stimuli, DNAzyme activity increases and RNA cleavage accelerates by a supplementary catalytic cofactor. In addition, this approach induces elevated O-2 and O-1(2) generation as auxiliary treatment, achieving simultaneously self-enhanced gene-photodynamic cancer therapy. These findings may advance the clinical trial of oligonucleotide drugs as tools for gene modulation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available